erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Hematuria D006417 13 associated lipids
Hemoglobin SC Disease D006450 2 associated lipids
Hemolysis D006461 131 associated lipids
Hepatitis, Viral, Human D006525 3 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Herpes Genitalis D006558 2 associated lipids
Herpes Zoster Ophthalmicus D006563 2 associated lipids
HIV Seropositivity D006679 15 associated lipids
Hoarseness D006685 2 associated lipids
Hyperbilirubinemia D006932 11 associated lipids
Hyperemesis Gravidarum D006939 2 associated lipids
Hyperhidrosis D006945 2 associated lipids
Hypersensitivity D006967 22 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Hypersensitivity, Immediate D006969 14 associated lipids
Hypersplenism D006971 3 associated lipids
Hypertension D006973 115 associated lipids
Hypotension D007022 41 associated lipids
Hypothermia D007035 19 associated lipids
Hypoventilation D007040 2 associated lipids
Impetigo D007169 3 associated lipids
Inappropriate ADH Syndrome D007177 4 associated lipids
Infant, Premature, Diseases D007235 7 associated lipids
Inflammation D007249 119 associated lipids
Intestinal Atresia D007409 3 associated lipids
Intestinal Obstruction D007415 6 associated lipids
Intestinal Pseudo-Obstruction D007418 5 associated lipids
Intraoperative Complications D007431 5 associated lipids
Ischemia D007511 18 associated lipids
Jaw Abnormalities D007569 1 associated lipids
Jejunal Diseases D007579 3 associated lipids
Keratoconjunctivitis D007637 3 associated lipids
Keratoderma, Palmoplantar D007645 1 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Obstetric Labor, Premature D007752 9 associated lipids
Labyrinth Diseases D007759 3 associated lipids
Lacrimal Duct Obstruction D007767 1 associated lipids
Laryngitis D007827 5 associated lipids
Legionellosis D007876 3 associated lipids
Legionnaires' Disease D007877 4 associated lipids
Leishmaniasis D007896 19 associated lipids
Leprosy D007918 8 associated lipids
Leukemia D007938 74 associated lipids
Leukemia P388 D007941 43 associated lipids
Leukemia, Lymphoid D007945 18 associated lipids
Lipidoses D008064 7 associated lipids
Listeriosis D008088 12 associated lipids
Liver Abscess D008100 6 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Liver Cirrhosis, Alcoholic D008104 17 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
STRYKER H et al. The allergenicity of erythromycin. 1958 Antibiotic Med Clin Ther (New York) pmid:13606766
GRUBER CM et al. An enteric compression coating. III. In vivo studies with ilotycin tablets. 1958 J Am Pharm Assoc Am Pharm Assoc (Baltim) pmid:13610707
BECKMANN G [Clinical experiences concerning complications & therapy of nasal furuncle]. 1958 Med Monatsschr pmid:13612730
MAZZACUVA D [Erythromycin in the treatment of infectious mononucleosis]. 1958 Clin Pediatr (Bologna) pmid:13523859
WICKMAN K Nosocomial infection with erythromycin-resistant straphylococci in a burns and plastic surgery unit. 1958 Acta Chir Scand pmid:13532327
ALEXANDER M [Erycin therapy of diphtheria bacterial carriers]. 1958 Arztl Wochensch pmid:13533121
BOITTELLE G and NOEL P [Recovery in a case of general paralysis with generalized skin eruption; role of erythromycin therapy]. 1958 Ann Med Psychol (Paris) pmid:13534092
MORER A [Treatment of carriers of diphtheria bacilli with erythromycin]. 1958 Medizinische pmid:13540776
SURMANN T [Treatment of diphtheria & diphtheria bacilli carriers]. 1958 Munch Med Wochenschr pmid:13541282
MITSUI Y et al. Treatment of trachoma with erythromycin-sulfacetamide ointment (CT-877). 1958 Antibiotic Med Clin Ther (New York) pmid:13583947
GRIFFITH RS et al. Preliminary studies on propionyl erythromycin. 1958 Antibiotic Med Clin Ther (New York) pmid:13583951
BOWER AG Anaphylactic death from erythromycin. 1958 Calif Med pmid:13585148
HEINRICH H et al. [Disinfection of diphtheria carriers with erythromycin]. 1958 Dtsch Gesundheitsw pmid:13585951
WILMOT AJ et al. Erythromycin in amebic liver abscess. 1958 Am. J. Trop. Med. Hyg. pmid:13595213
BARBER M et al. Staphylococcal infection resistant to chloramphenicol, erythromycin, and novobiocin; effect of antibiotic combinations on the emergence of resistant strains. 1958 Br Med J pmid:13596614
PROTIVINSKY R and ZELLINGER O [Therapy of mixed infection tuberculous empyema; preliminary report]. 1958 Wien. Klin. Wochenschr. pmid:13570054
[Not Available]. 1958 Ann Pharm Fr pmid:13571728
DE FRANCO VJ The efficacy of erythromycin in the control and prevention of an endemic staphylococcal infection in a large private hospital nursery. 1958 Antibiotic Med Clin Ther (New York) pmid:13571962
SACCHETTI G and BROCCA F [Erythromycin in therapy of diphtheria carriers]. 1958 Clin Ter pmid:13573649
MULLER WK [Erythromycin treatment of spinal pachy- and leptomeningitis with a contribution to the clinical picture of spinal epidural abscess]. 1958 Wien Med Wochenschr pmid:13581715
SEDALLIAN P et al. [Choleriform subacute enteritis caused by staphylococcus following antibiotic therapy; treatment with erythromycin & intravenous hydrocortisone hemisuccinate]. 1958 Lyon Med pmid:13551212
REISCH AJ et al. Triacetyloleandomycin and erythromycin in serum; comparison of concentrations and of antibacterial effects. 1958 Proc Staff Meet Mayo Clin pmid:13542650
VERCILLO L and ZANGAGLIA O [Combined erythromycin and vaccine in therapy of melitensis]. 1958 Gazz Med Ital pmid:13562444
EDELSTEIN AJ Treatment of infected acne with erythromycin. 1958 Antibiotic Med Clin Ther (New York) pmid:13509625
POWELL SJ et al. A comparison of erythromycin, spiramycin and novobiocin in the treatment of acute amoebic dysentery. 1958 J Trop Med Hyg pmid:13514846
BIRO L and GRABER H [Erythromycin and patients treated with erythromycin]. 1958 Orv Hetil pmid:13623213
KUNIN CM et al. Antibacterial activity of serum after oral doses of triacetyloleandomycin, erythromycin, potassium penicillin V and penicillin V. 1958 Pediatrics pmid:13578533
SCOTT A Treatment of boils with erythromycin and with antibiotic E 129. 1958 Br Med J pmid:13546654
BARAN LR [Paradoxical development of a profuse eruption of molluscum contagiosum treated with erythromycin, then with tetracycline]. 1958 Jun-Jul Bull Soc Fr Dermatol Syphiligr pmid:13608249
IAKOBSON LM et al. [Attempted international standardization of erythromycin]. 1958 Mar-Apr Antibiotiki (Mosc) pmid:24544839
LOUGHLIN EH et al. Antibiotic therapy of acute gonococcal infections; a study of the comparative efficacy of triacetyloleandomycin, erythromycin, and penicillin V in the treatment of acute gonococcal urethritis. 1958-1959 Antibiot Annu pmid:13637747
STEPHENS VC and CONINE JW Esters of erythromycin. III. Esters of low molecular weight aliphatic acids. 1958-1959 Antibiot Annu pmid:13637765
LEE CC et al. Pharmacology and toxicology of erythromycin propionate. 1958-1959 Antibiot Annu pmid:13637766
GRIFFITH RS Laboratory and clinical studies with erythromycin propionate. 1958-1959 Antibiot Annu pmid:13637767
PERRY DM et al. Clinical and laboratory studies of erythromycin propionate. 1958-1959 Antibiot Annu pmid:13637768
KUNIN CM et al. Absorption of erythromycin propionate and triacetyloleandomycin. 1958-1959 Antibiot Annu pmid:13637769
METZGER WI et al. Laboratory and clinical studies of intramuscular erythromycin. 1958-1959 Antibiot Annu pmid:13637770
BURDIN JC et al. [Comparative study of the antistaphylococcal bacteriostatic activity of 4 antibiotics: erythromycin, spiramycin, oleandomycin and novobiocin]. 1959 Rev Med Nancy pmid:13806021
ANDERSON RC et al. Pharmacology and toxicology of propionyl erythromycin ester lauryl sulfate. 1959 J Am Pharm Assoc Am Pharm Assoc pmid:13848813
STEPHENS VC et al. Esters of erythromycin. IV. Alkyl sulfate salts. 1959 J Am Pharm Assoc Am Pharm Assoc pmid:13854943
SHIMOHIRA M [Mode of action of the antagonism and additive effects caused by the combination of erythromycin and other antibacterial substances. I. On the in vitro combination of penicillin and erythromycin, especially in the matter of the antagonism phenomenon]. 1959 Jpn. J. Microbiol. pmid:13856354
VIALLIER J et al. [Comparative study of the blood level of active erythromycin obtained in the human organism by administration of base or of propionate]. 1959 C. R. Seances Soc. Biol. Fil. pmid:13842057
VON WANDRUSZKA R [Local treatment of male adnexitis with antibiotics, especially erythromycin]. 1959 Medizinische pmid:13643478
MONTGOMERY CH and KNOX JM Erythromycin in the treatment of early syphilis; a preliminary report. 1959 AMA Arch Derm pmid:13669748
CLUZEL R et al. [Combination erythromycin-oleandomycin: favorable bactericidal effect on pathogenic staphylococci]. 1959 Sem Hop pmid:13624776
HIRSCH HA et al. Antibacterial activity of serum of normal men after oral doses of erythromycin propionate and triacetyloleandomycin. 1959 N. Engl. J. Med. pmid:13632901
HIRSCH HA and FINLAND M Effect of food on the absorption of erythromycin propionate, erythromycin stearate and triacetyloleandomycin. 1959 Am. J. Med. Sci. pmid:13661157
PERRY DM et al. Triacetyloleandomycin and erythromycin: a comparison of in vitro activity and of blood levels obtained after oral administration. 1959 Antibiotic Med Clin Ther (New York) pmid:13661850
TIDWELL RA and LEWIS D Erythromycin prophylaxis: a four year study. 1959 Antibiotic Med Clin Ther (New York) pmid:13661855
HALLETT WY et al. Chemoprophylaxis in chronic obstructive pulmonary emphysema: a twelve-week study with erythromycin. 1959 Am. Rev. Respir. Dis. pmid:14399110